VINCUE SECURES $93 MILLION IN GROWTH CAPITAL LED BY WAVECREST GROWTH PARTNERS

Investment will accelerate VINCUE’s rollout of its AI-first platform built on its new Protos foundation, and fund a significant expansion of the company’s go-to-market, product, and dealer performance organizations.

KANSAS CITY, Mo., Nov. 17, 2026 — VINCUE, the creator of the industry’s leading end-to-end vehicle lifecycle intelligence platform, today announced it has closed $93 million in growth capital led by Wavecrest Growth Partners, with participation from existing investor FM Capital, a strategic investor in the mobility market. The investment will fund the acceleration of VINCUE’s product roadmap and a significant expansion of the company’s go-to-market and dealer services teams.

The investment follows two consecutive years of nearly 100% growth for VINCUE, driven by deep investment and expertise in vehicle acquisition and merchandising. VINCUE’s agility keeps their solution market-synced, and their current release is well-timed as franchise dealers have started relying more heavily on used vehicle operations as a primary profit center.

“We didn’t raise this capital to keep pace with where the industry is today, we raised it to build what the industry needs next,” said Chris Hoke, Founder and Chief Executive Officer of VINCUE. “Every dollar of this investment goes toward two things: building AI as the technical foundation of the platform, and making sure our customers and prospects get the full value of that technology in their stores. Leading with and for our dealers, we are defining what retail automotive intelligence looks like for the next generation of dealerships.”

Concurrent with the financing, the Company has added new members to VINCUE’s board of directors, including Deepak Sindwani, Managing Partner at Wavecrest Growth Partners, and Anthony Giannobile, Principal at Wavecrest. They will advise the executive leadership team on strategic direction and operational scale, as well as facilitate strategic business and technical partnerships within the extensive Wavecrest portfolio of companies.

“VINCUE isn’t chasing a category, it’s creating a new one,” said Sindwani. “This team is setting a benchmark for retail automotive intelligence, with direct margin enhancement capabilities across vehicle pricing, acquisition, inventory management, and other areas. They are doing it with a level of discipline and product vision you rarely see at this stage. We are very excited to partner with Chris, Danny, and the team to further expand their products and market share. We believe VINCUE is one of the most exciting companies in automotive technology today.”

VINCUE Co-Founder and President Danny Zaslavsky said the partnership was as much about fit as capital. “We were honored to learn that Wavecrest has been watching our progress for several years. They grew to not just understand our business, but believe in our people, our culture, and what we are doing for dealers,” said Zaslavsky. “We know we have the right partner to help us realize what VINCUE can and needs to become. This capital is the fuel we need to pursue an aggressive product roadmap and provide a higher level of support and strategy than dealers have ever experienced. Dealers on VINCUE will benefit from a foundation being built for where they need to go, not where they’ve been. We’re excited to accelerate our traction with the dealers who have not yet adopted VINCUE.”

VINCUE has always approached its growth through product development and innovation. At its sold-out UNLEASHED 2026 conference in Kansas City, the company introduced Protos Intelligence to more than 550 dealers, partners, and industry professionals. Protos, Greek for “first,” is a ground-up rebuild of the VINCUE platform with AI at its foundation rather than layered on top as a widget or plug-in.

“The internet gave dealers access to data and information in ways we never had,” said Andy Wright, Managing Partner at Vinart Dealerships. “But now, artificial intelligence gives us the ability to analyze and act on that data in ways that no single person would have the capacity to. Just as the internet redefined inventory management a generation ago, VINCUE is redefining it for the AI era, transforming inventory from something dealers manage into something that continuously informs smarter, faster, and more profitable decisions.”

With Protos, dealers can type or speak questions directly to their own inventory data and get answers in plain language, the same way users use ChatGPT or Claude. Its pricing models include Signal Appraisal, which predicts a vehicle’s retail sale price and recalculates the appraisal as managers adjust gross and turn targets, accounting for holding costs, and the Predictive Market Report, which forecasts wholesale values instead of reporting past auction results.

At the conference, VINCUE also announced early results from its first 100 dealers using Buy Center Pro for Service Lane Acquisition. From the main stage, Zaslavsky reported that in the first 9 months of the year, dealers using Buy Center Pro and its AI Agent, Benjamin, have generated an additional $5M in front end gross from service lane acquisition alone. They also reported more than 20 partner integrations, including Tekion, DriveCentric, LumaScanner, AppraisalPRO, and Auto Hauler Exchange, deepening the connected systems dealers already rely on every day.

Existing investor FM Capital added to its position in the Company. Mark Norman, Managing Partner at FM Capital, said: “VINCUE has built a product that leading dealers rely on every day, and the team has scaled it with real discipline. We’re excited to continue backing Chris, Danny, and the team as they bring Protos to more dealers.”

TD Securities served as financial advisor to VINCUE throughout the transaction, guiding deal structure and negotiations from start to close. Kennyhertz Perry Attorneys at Law and Hogan Lovells Cadwalader served as counsel to the Company, and Gunderson Dettmer served as counsel to Wavecrest.

VINCUE was founded by Chris Hoke, Danny Zaslavsky, Brian Kellogg, and Jeff Rice as a mobile appraisal app. It has since expanded to cover every stage of the vehicle lifecycle, from plan to buy to manage to sell, replacing multiple systems and disciplines with a single platform. Today, VINCUE offers a unified vehicle lifecycle management platform that unifies all inventory data, actions, and insights.

ABOUT VINCUE

VINCUE is the retail automotive intelligence platform that unifies the vehicle lifecycle, from plan to buy to manage to sell, inside a single connected system. Built on a philosophy of innovation through integration, VINCUE brings appraisal, acquisition, pricing, stocking, and merchandising together in one workflow, replacing the patchwork of disconnected tools dealers have relied on for decades. Through Protos, its AI-native technology foundation, VINCUE harnesses data at every stage to help dealers move faster and more profitably, maximizing gross and turn on every unit. VINCUE is expanding rapidly across the automotive industry. Learn more at vincue.com.

ABOUT WAVECREST GROWTH PARTNERS

Wavecrest Growth Partners is a growth equity firm focused on investing in and partnering with leading B2B software and technology-enabled services companies based in North America and Western Europe. Wavecrest targets investments in high-growth companies with proven products and business models and brings a differentiated combination of investing and operating experience to help accelerate growth and profitability. Representative investments include Carpool Logistics, Impel, RapidWorks, Recentive Analytics, and numerous others. For more information, visit wavecrestgrowth.com.

ABOUT FM CAPITAL

FM Capital is a venture capital firm focused on technologies transforming the transportation industry. The firm’s investor base is drawn directly from the automotive ecosystem, including dealers, distributors, OEMs, suppliers, and insurers, giving portfolio companies direct commercial access to the industry alongside capital. FM Capital typically invests between $5 million and $15 million in early to growth stage companies building transformative solutions in transportation, and closed its fourth fund at $240 million in 2025. The firm is led by Managing Partners Chase Fraser and Mark Norman. Learn more at fmcap.com.

SOURCE VINCUE

Isomorphic Labs announces $5 Billion Series C funding

Greenoaks and Sequoia Capital co-lead the oversubscribed round as Isomorphic Labs continues to advance its foundational simulation models, progress and scale its internal and partnered medicine candidate pipeline, and build its global AI-led bioengineering infrastructure

LONDON, Nov. 17, 2026 — Isomorphic Labs, an AI company focussed on designing and developing new medicines, today announced a $5 Billion Series C financing round. The round was co-led by Greenoaks and Sequoia Capital, alongside Andreessen Horowitz (a16z) and several other new investors, with continued significant investment from Alphabet. The round also included participation from all existing investors: Thrive Capital, MGX, GV, CapitalG, Temasek and the UK Sovereign AI Fund.

Isomorphic is scaling its proprietary drug design engine (IsoDDE) and therapeutic candidate pipeline designed with AI to deliver the next generation of medicines. IsoDDE unifies a suite of foundational simulation AI models that natively work across multiple therapeutic areas and drug modalities. IsoDDE explores vast chemical spaces to enable Isomorphic’s world-class team to design, refine, and deliver exquisitely engineered molecules with optimal drug-like properties.

The breadth and precision of the simulation models within IsoDDE push predictions towards experimental accuracy and provide a suite of capabilities to advance innovative medicines. Combined with powerful proprietary agents that navigate and reason over highly complex biological systems, these models directly and repeatedly translate into advancements across the company’s multi-modality pipeline of therapeutic candidates, addressing some of the most challenging problems in the industry. This momentum is yielding positive preclinical results, both for internal programs in oncology and immunology and with partners, setting the stage for clinical entry.

This new capital accelerates the scientific breakthroughs and proprietary AI advances being made by Isomorphic. The company will continue to mature IsoDDE as well as expand deeper into new biology with highly advanced models. To deliver new and transformative classes of therapeutics, Isomorphic is creating a partner ecosystem to advance the understanding of mechanistic disease biology. In parallel, the company is building the global infrastructure required to power the future of AI-led bioengineering. Proceeds will also support the company’s continued build of scalable AI-first translational and clinical development infrastructure as it advances its drug candidates to clinical trials. 

“When we founded Isomorphic, our conviction was that biology could be understood and modelled at the most fundamental molecular level and radically accelerated through AI,” said Sir Demis Hassabis, Founder and CEO of Isomorphic Labs. “Our drug design engine is generating molecules with unprecedented precision and speed. This round enables us to accelerate our progress: building foundational biology models, deepening our systemic disease understanding, and driving our first therapeutic programs towards clinical trials to deliver tangible impact for patients.”

“Every week we are making repeatable scientific advancements enabled by our models,” said Max Jaderberg, President of Isomorphic Labs. “These translate directly into better molecular profiles with the potential to be new medicines and unlock some of the hardest problems in drug discovery. Our interdisciplinary teams combine world-leading machine learning researchers with top-class drug hunters and together they are routinely solving complex biological problems that have stalled traditional research for decades. We are translating our discoveries directly into potential life-changing medicines, built on the infrastructure we are establishing for the future of bioengineering with this investor backing.”

“Discovering and developing new medicines is an optimization challenge of almost infinite scale,” said Neil Mehta, Founder and Managing Partner of Greenoaks. “Isomorphic is transforming that journey, building deep learning systems that can predict complex biological behaviors with remarkable accuracy and systematically map the path to new medicines. We believe Demis, Max, and the Isomorphic team are building the future of AI-led drug discovery and we are proud to partner with them on this essential mission.”

“Isomorphic Labs is building foundational technology for the future of medicine,” said Konstantine Buhler, Partner at Sequoia Capital. “It’s inspiring to see the Isomorphic team translate advanced AI into a growing portfolio of drug candidates. Using AI to improve human health is one of the most important challenges of our generation. We’re proud to co-lead this round and help further scientific discovery in medicine.”

ABOUT ISOMORPHIC LABS

Isomorphic Labs was founded in 2021, to transform drug discovery with the power of artificial intelligence, ushering in a new era of biomedical breakthroughs. Isomorphic Labs is led by CEO Sir Demis Hassabis and President Max Jaderberg. Isomorphic Labs has built a world-leading AI drug design engine comprising foundational AI models that are capable of working across multiple therapeutic areas and drug modalities. The company is continually innovating on model architecture and developing cutting-edge capabilities to advance drug design. Isomorphic Labs is headquartered in London and has office locations in Cambridge, Massachusetts and Lausanne, Switzerland. Isomorphic Labs is advancing a broad and ambitious drug design portfolio through partnered programs and wholly-owned internal programs. For more information, go to www.isomorphiclabs.com and follow us on LinkedIn and X.

Synthesys Announces Collaboration with WisdomTree Following Registration of Three Tokenized Funds in Singapore

Synthesys Network will enable regulated intermediaries to access WisdomTree’s tokenized fund portfolio, starting with three funds spanning money markets, U.S. large-cap equities and technology strategies, following approval for distribution in Singapore.

SINGAPORE and NEW YORK, Nov. 17, 2026 — Synthesys, the financial market infrastructure company for tokenized capital markets, today announced a collaboration with WisdomTree (NYSE: WT), a global financial innovator, making WisdomTree’s tokenized funds accessible through regulated channels integrated into Synthesys Network.

Under the collaboration, the funds become accessible to regulated distribution partners connected through Synthesys Network a connective infrastructure layer enabling regulated distribution to over 80+ distribution channels globally. The first of these partners is Pinetree Securities, who will promote the WisdomTree tokenized funds to certain eligible institutional clients in Singapore that qualify under applicable laws, with further distribution partners to follow. 

The funds include the WisdomTree Money Market Digital Fund (WTGXX), WisdomTree 500 Digital Fund (SPXUX) and WisdomTree Technology and Innovation 100 Digital Fund (TECHX). WisdomTree has registered the funds in Singapore as restricted schemes, making them available to a wider range of eligible investors. Together, they provide eligible investors with access to USD cash management, U.S. large-cap equities and technology-focused exposure through tokenized, regulated investment vehicles.

Most tokenized funds still operate largely in silos. Each bank, fintech, brokerage or platform that wants to build on them must integrate with each manager separately, chain by chain and jurisdiction by jurisdiction, so even the best products reach only a fraction of their addressable market. Synthesys Network enables the connectivity and operational layer linking regulated distribution channels, spanning banks, payment service providers, fintechs and financial institutions across jurisdictions, to institutional-grade tokenized products through a single integration.

More than 80 regulated channels connected to Synthesys Network will be able to access the funds without building and maintaining a separate bilateral integration with WisdomTree, subject to each channel’s regulatory permissions and investor eligibility requirements, including completion of onboarding and investor due diligence.

“WisdomTree is a pioneer in the tokenized fund industry, with one of the largest tokenized portfolios spanning across different strategies. We’re excited to support their expansion with Synthesys Network, bringing these funds to more regulated distribution channels globally. When distribution stops being the bottleneck, the best products win, and investors get access that no longer depends on where they happen to bank.”

— Darien Poh, CEO, Synthesys

WisdomTree brings significant experience and scale to the Synthesys Network. The global asset manager offers 15 SEC-registered tokenized funds spanning money markets, equities, fixed income, asset allocation and alternatives across eight public blockchains. Its tokenized fund assets surpassed US$1.2 billion in September 2026, up from approximately US$770 million at the start of the year.

“Onchain finance is global by nature, and Singapore is an important market for its next stage of growth. Working with Synthesys gives us a practical way to bring WisdomTree’s tokenized funds to more eligible investors through the regulated channels they already use. If we continue to make regulated products easier to access and use across markets, then adoption will only continue to follow.”

— Vinh Tran, Associate Director of Business Development for WisdomTree Onchain

Availability through each channel remains subject to that channel’s regulatory permissions and investor eligibility. Access to products via Synthesys Network is available exclusively to regulated intermediaries and, through them, to eligible investors under applicable law.

###

About Synthesys and Pinetree

Synthesys is a financial market infrastructure company for tokenized funds and securities. Its flagship product, Synthesys Network, is an issuer-agnostic connectivity layer that gives regulated distribution channels such as banks, payment providers, fintechs and brokerages access to institutional-grade tokenized products through a single integration, with compliance and investor eligibility enforced at the network layer. Network today carries tokenized funds, offering yields in over ten currencies to over 80+ distribution channels globally. Alongside Network, Synthesys’ product suite enables traditional financial institutions to seamlessly build into the tokenized economy, including Synthesys Mint and Zodiac.

Learn more at synthesys.co. 

The foregoing activities with respect to the WisdomTree tokenized funds are facilitated via Pinetree Securities Pte. Ltd., the holder of a Capital Markets Services License and regulated by the Monetary Authority of Singapore to conduct the regulated activities, including dealing in capital markets products that are securities or collective investment schemes. Pinetree’s core business is to support its clients in any investment process, be it through the discovery and sharing of potential investment opportunities or through the identification and introduction of potential investors, leveraging its expertise and presence in the Singapore and South-East Asia markets.

Disclaimer: This communication is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any security or fund interest in any jurisdiction. Synthesys does not offer, sell or distribute securities. Products accessible via Synthesys Network are made available by regulated intermediaries, such as Pinetree, acting within their own regulatory permissions, and availability is subject to investor eligibility and jurisdiction.

About WisdomTree

WisdomTree is a modern global asset manager with capabilities across public markets, private markets, tokenization and onchain finance. We offer a diverse suite of exchange-traded products, models and solutions, private market investments and blockchain-enabled products and services, helping investors shape their financial future and financial professionals grow their businesses. Through WisdomTree Onchain™, we combine tokenized investment products, infrastructure and distribution capabilities into an integrated financial services platform serving retail and institutional investors.

WisdomTree currently has approximately US$172.3 billion in assets under management globally, inclusive of assets managed by Ceres Partners, LLC as of the last reportable period.

For more information about WisdomTree Onchain, visit: https://www.wisdomtree.com/onchain

Please visit us on X at @WisdomTreeOnchn.

WisdomTree® is the marketing name for WisdomTree, Inc. (NYSE: WT) and its subsidiaries worldwide. 

WisdomTree Digital Management, Inc., serves as the investment adviser to the WisdomTree Money Market Digital Fund (WTGXX), WisdomTree 500 Digital Fund (SPXUX) and WisdomTree Technology and Innovation 100 Digital Fund (TECHX) (the “Funds”), which are series of WisdomTree Digital Trust. WisdomTree Digital Management, Inc. and WisdomTree Digital Trust are registered with the U.S. Securities and Exchange Commission.  WisdomTree Digital Management has also registered the Funds as restricted schemes with the Monetary Authority of Singapore.

Investors should carefully consider the investment objectives, risks, charges and expenses of the Funds before investing, which may be obtained via Pinetree. There are risks involved with investing, including the possible loss of principal. Past performance does not guarantee future results.

You could lose money by investing in a Fund, including WTGXX. Although WTGXX  seeks to preserve the value of your investment at $1.00 per share, it cannot guarantee it will do so. An investment in the WTGXX is not a bank account and is not insured or guaranteed by the Federal Deposit Insurance Corporation or any other government agency. The Fund’s adviser is not required to reimburse the Fund for losses, and you should not expect that the adviser will provide financial support to the Fund at any time, including during periods of market stress.

Potential products and services, as well as applicable launch timing and associated fees, are in development, may change or may never become available, including due to regulatory considerations. Any information provided and/or plans associated herewith are subject to change without notice, and WisdomTree is under no obligation to provide additional information.

Media Contacts

Synthesys 
Media
Equitize Pte Ltd
[email protected]

WisdomTree
Media Relations
WisdomTree, Inc.
Jessica Zaloom
+1.917.267.3735
[email protected]

Investor Relations
WisdomTree, Inc.
Jeremy Campbell
+1.917.267.3859
[email protected]

SOURCE Synthesys

CPP Investments and Ontario Teachers’ to join Nordic Capital as owners of Cary Group to support its continued international expansion and long-term development

  • The new joint ownership will aim to accelerate growth through strategic acquisitions, operational excellence and digitalisation
  • The transaction builds on Cary Group’s significant transformation and international growth under Nordic Capital’s ownership since 2018

STOCKHOLM, Nov. 17, 2026 — Canada Pension Plan Investment Board (“CPP Investments”), Ontario Teachers’ Pension Plan Board (“Ontario Teachers'”), and Nordic Capital today announced an agreement to form a new consortium in Cary Group (“the Group”), a leading European provider of vehicle glass repair and replacement services, to support its next phase of growth. CPP Investments and Ontario Teachers’ will invest alongside Nordic Capital, which will make a new investment in Cary Group following the exit of its current holding. Each investor will hold an approximately equal ownership of the business. CVC Capital Partners XIII, which has been a co-owner since 2022, will fully exit its shareholding following a successful partnership.

The transaction marks an important new chapter for Cary Group following several years of significant growth and international expansion. Nordic Capital, CPP Investments and Ontario Teachers’ will combine their sector expertise, operational capabilities and international networks to drive Cary Group’s next phase of growth. Working closely with management, the consortium will focus on strengthening Cary Group’s position in existing markets, pursuing further international expansion through organic growth and strategic acquisitions, and advancing operational excellence and digitalisation.

Headquartered in Stockholm, Cary Group provides vehicle glass repair and replacement services, alongside a complementary offering in auto body repair. Today, it operates across 13 European countries, with approximately 1,800 workshops and 4,500 employees. The Group generated net revenue of SEK 9 billion (EUR 820 million), LTM October 2026,  and handled approximately 1.4 million vehicle glass jobs, reflecting the scale of its operations and its established position as a partner to insurers and motorists across Europe.

“Cary Group has achieved remarkable progress during Nordic Capital’s ownership since 2018, growing from a Swedish business with just over 100 workshops to a leading European platform with approximately 1,800 workshops across 13 countries through a combination of organic growth and strategic acquisitions. We would like to thank CVC for its partnership and contributions during the last four years. The decision to reinvest reflects a strong conviction in the Group’s potential, and Nordic Capital looks forward to building on this success with this new joint ownership,” said Joakim Andreasson, Partner and Co-Head of Services & Industrial Tech, Nordic Capital Advisors.

“Cary Group has established a leading position in Europe with a resilient business model and a strong track record of organic growth and strategic acquisitions. We see significant opportunity to continue building on this momentum across Europe and look forward to working alongside Nordic Capital, Ontario Teachers’ and the management team as the company enters its next phase of growth. The investment reflects CPP Investments’ strategy of investing in high-quality businesses with strong market positions that have the potential to deliver attractive long-term, risk-adjusted returns for the CPP Fund,” said Sam Blaichman, Managing Director and Head of Direct Private Equity at CPP Investments.

“This investment is exactly what we look for: a leading company, a high-quality team, and a sector with structural tailwinds. Cary Group’s proven model and challenger position give it a clear runway for growth across Europe, and we’re glad to be doing this alongside partners we know well in Nordic Capital and CPP Investments,” said Inaki Echave, Head of EMEA Private Capital at Ontario Teachers’. 

“Over the past few years, we have built a leading European business by consolidating a fragmented market through strategic acquisitions. At the same time, we have achieved strong organic growth by working closely with our customers and investing in operational improvements. We still see great opportunities ahead, and with this new ownership group, we are well positioned to accelerate our expansion in Europe and internationally, and to further strengthen our customer offering,” said Anders Jensen, CEO of Cary Group.

The ownership will be a consortium between Nordic Capital, CPP Investments and Ontario Teachers’, each holding an approximately equal co-control position. Nordic Capital will realise its existing investment in Cary Group and make a new investment alongside CPP Investments and Ontario Teachers’, reflecting its continued conviction in the company’s long-term growth prospects. Ontario Teachers and CPP Investments are expected to invest EUR 545 million (CAD 859 million) and EUR 500 million (CAD 790 million) respectively.

The transaction is subject to customary closing conditions and regulatory approvals and is expected to close in H1 2027.

Media contacts

Nordic Capital 
Katarina Janerud
Communications Manager, Nordic Capital Advisors
+46 8 440 50 50
[email protected] 

CPP Investments
Steve McCool
Public Affairs & Communications
+44 7780 224 245
[email protected]

Ontario Teachers’
Henrietta Dehn
Director of Communications, Ontario Teachers’
[email protected] 

Anelia Fikiina
Director, Kekst CNC
+44 7970 952 774
[email protected] 

Cary Group
Helene Gustafsson Director Corporate Communications
+46 708 68 40 50
[email protected] 

About Nordic Capital

Nordic Capital is a leading international private equity investor and subsector specialist dedicated to building stronger, more resilient businesses through transformative, long-term growth in partnership with management teams. With over 35 years of experience, Nordic Capital currently manages approximately EUR 39 billion in assets, investing in middle-market companies across Northern Europe and North America. Rooted in its Nordic heritage and values, it combines global reach with local presence through dedicated sector investment advisory teams, bringing deep expertise across its core sectors: Healthcare, Technology & Payments, Financial Services, and Services & Industrial Tech. Through active ownership, strong operational capabilities, a global network of experts and technology-enabled transformation, Nordic Capital helps companies scale, innovate and become sustainable leaders. For more information, visit www.nordiccapital.com or connect on LinkedIn.

“Nordic Capital” refers to, depending on the context, any, or all, Nordic Capital branded entities, vehicles, structures, and associated entities. The general partners and/or delegated portfolio managers of Nordic Capital’s entities and vehicles are advised by several non-discretionary sub-advisory entities, any or all of which are referred to as “Nordic Capital Advisors”.

About CPP Investments

Canada Pension Plan Investment Board (CPP Investments™) is a professional investment management organization that manages the Canada Pension Plan Fund in the best interest of the more than 22 million contributors and beneficiaries. In order to build diversified portfolios of assets, we make investments around the world in public equities, private equities, real estate, infrastructure, fixed income and alternative strategies including in partnership with funds. Headquartered in Toronto, with offices in Hong Kong, London, Mumbai, New York City, São Paulo and Sydney, CPP Investments is governed and managed independently of the Canada Pension Plan and at arm’s length from governments. At September 30, 2026, the Fund totalled C$866.2 billion. For more information, please visit www.cppinvestments.com or follow us on LinkedIn, Instagram or on X @CPPInvestments.

About Ontario Teachers’

Ontario Teachers’ Pension Plan Board (Ontario Teachers’) is a global investor with net assets of $303.2 billion as at June 30, 2026. Ontario Teachers’ is a fully funded defined benefit pension plan, and it invests in a broad array of asset classes to deliver retirement security for 346,000 working members and pensioners. For more information, visit otpp.com and follow us on LinkedIn.

About Cary Group

Cary Group is a leading European vehicle glass company, offering repair and replacement for private motorists, fleets, leasing companies and insurers. With around 1,800 workshops and 4,500 employees, we operate through several well-known brands across Europe. The company started in 1947 with Ryds Bilglas in Sweden. For more information, visit www.carygroup.com.

This information was brought to you by Cision http://news.cision.com

The following files are available for download:

Boyuan Capital Completes Final Close of RMB 1.1 Billion Fund II, Focusing on Industrial AI and Globalization

SHANGHAI, Nov. 17, 2026 — Boyuan Capital has completed the final close of Fund II at approximately RMB 1.1 billion. As the Bosch Group’s only market-oriented investment platform, Boyuan Capital connects Chinese technological innovation with global industrial resources, helping promising businesses translate breakthroughs into scalable commercial applications.

Fund II has attracted a diverse group of limited partners, including national-level funds of funds, social security funds, industrial groups, financial institutions and local government-guided funds. Among them is STIHL, the German outdoor power equipment leader, whose participation further expands Boyuan’s international industrial ecosystem and cross-border collaboration opportunities.

From Industrial Investment to Co-Creation

Building on Fund I’s investments across automotive, new energy and intelligent manufacturing, Fund II concentrates on: deploying AI and embodied intelligence in industrial environments; creating new businesses through carve-outs, joint incubation and collaboration within Bosch’s industrial value chain; and supporting the global expansion of China’s advanced manufacturing companies.

This evolution reflects a shift from identifying opportunities within established value chains to actively shaping new businesses, connecting emerging technologies with industrial capabilities, customer relationships and global market access.

“Artificial intelligence is becoming a major force shaping the future of industry. However, technologies can only create lasting value when they are applied in industrial settings and solve real-world problems,” said Dr. Hongquan Jiang, Managing Partner and Chairman of Boyuan Capital. He highlighted Bosch’s industrial expertise, engineering capabilities and global network as key resources for identifying long-term opportunities.

Michael Zhu, Managing Partner and CEO of Boyuan Capital, emphasized the importance of moving beyond financial investment to actively building industrial ecosystems.

“We look further: Can its technology be deployed in real industrial environments? Can it deliver products and solutions at scale? And can the company bring China’s engineering and manufacturing capabilities to global markets?” he said.

Fund II has invested in seven companies. Representative investments include Bowintec, jointly incubated by Boyuan and Galbot to advance industrial embodied intelligence; Weifu Smart Sensing, jointly incubated by Weifu High-Tech and Bosch; robotics companies Linkhou Robotics and Inspire Robots; and X-Motors, which is exploring international opportunities starting in Indonesia.

Through OpenBosch and Bo-ignition, Boyuan connects portfolio companies with industrial use cases, engineering capabilities, customers and global networks, accelerating technology validation, commercialization and international expansion.

Boyuan will continue connecting technology, capital and industrial resources, transforming Chinese innovation into globally competitive industrial businesses.

Faex Health Brings AI-Powered Digestive Health Monitoring to HLTH 2026, Advancing the Conversation Around Preventive Healthcare

Co-Founder and CEO Landon Nattrass joins healthcare innovators in Las Vegas 
to explore how artificial intelligence, continuous monitoring and accessible technology can support earlier intervention and more connected care

LAS VEGAS, Nov. 16, 2026 — Faex Health, a digital health company that has developed AI-powered tools to help people better understand and track digestive wellness, is showcasing its groundbreaking app at HLTH 2026, taking place through Wed., Nov. 18, at The Venetian Expo in Las Vegas. Co-Founder and CEO Landon Nattrass is sharingFaex Health’s first-of-its-kind approach to continuous gastrointestinal health monitoring to healthcare leaders, investors and strategic partners, demonstrating how artificial intelligence can help bridge a longstanding gap in preventive care by transforming everyday digestive health information into actionable insights.

Centered on the theme “The Age of Intelligent Healthcare Is Here,” HLTH 2026 brings together healthcare executives, clinicians, investors, technology innovators and policymakers to explore the technologies and partnerships shaping the future of healthcare delivery. Faex Health’s participation underscores the growing potential for AI-powered tools to make preventive health monitoring more accessible, continuous, and scalable.

Through computer vision and machine learning, the Faex platform analyzes smartphone images of stool alongside user-reported symptoms and other contextual information. The technology organizes digestive health indicators, identifies patterns, and tracks changes over time, helping users better understand their digestive wellness while supporting opportunities for more informed conversations with healthcare professionals.

“Healthcare has made tremendous advances in diagnosing and treating diseases, but we still overlook valuable information that people generate every day,” said Landon Nattrass, co-founder and CEO of Faex Health. “Our vision is to make digestive health monitoring as accessible and routine as tracking sleep, activity, or heart rate. HLTH brings together the organizations and decision-makers who can help move innovations like ours from promising technology into meaningful global healthcare applications.”

Unlike conventional approaches that often depend on periodic appointments, laboratory testing, or the onset of symptoms, Faex Health has developed technology designed to support ongoing digestive wellness tracking through a familiar device: the smartphone. The platform allows users to capture images, document symptoms, and review changes in digestive health indicators over time. Its AI-assisted tools provide structured wellness information and educational guidance intended to complement, rather than replace, professional medical evaluation.

“Faex Health is automatic and easy to use for both professionals and patients. For professionals, it allows us to review data quickly, verify each participant’s status, and keep the study under orderly control,” said Cristian Araya Orostica, registered nurse at Hospital Dr. Sótero del Río in Santiago, Chile, where Faex Health is participating in FECAL-AI, an ongoing clinical validation study evaluating its AI-powered technology for colorectal cancer prescreening.

Faex Health is exploring applications for healthcare providers, health plans, employers, and population health organizations seeking scalable approaches to preventive health engagement. The company’s broader platform strategy includes tools for organizing longitudinal digestive health information into structured summaries that may support clinical review and institutional health programs, subject to applicable requirements and validation.

As healthcare organizations increasingly evaluate artificial intelligence for preventive care, Faex Health is emphasizing the importance of responsible deployment, clinical validation, and appropriate integration with established healthcare practices. The company is also investigating potential applications of its technology in gastrointestinal prescreening and clinical research, including approaches that may help identify individuals who could benefit from additional medical evaluation. These investigational applications remain distinct from the company’s current wellness-monitoring capabilities and are not intended to replace established colorectal cancer screening, diagnostic procedures or professional medical judgment.

“The real opportunity for AI in healthcare is not simply generating more information. It is helping make meaningful information available at the right time, in a way that patients and healthcare professionals can actually use,” Nattrass added. “For health plans, employers and healthcare systems, that means exploring technologies that can encourage engagement, improve visibility into health trends and potentially reduce barriers to preventive care.”

During HLTH 2026, Faex Health is presenting the cutting-edge technology to healthcare organizations, investors, and collaborators interested in the intersection of artificial intelligence, digestive health, longitudinal monitoring, and population health. The company sees opportunities for its technology to complement existing healthcare systems by supporting accessible, non-invasive participation, and providing structured information that may help individuals and care teams recognize changes in digestive wellness over time.

Nattrass is available for media interviews regarding responsible AI in healthcare, the evolution of preventive health monitoring, the challenges of building clinically credible digital health technologies and the role of strategic partnerships in bringing emerging innovations to market.

For more information or to schedule an interview, contact Shawna Seldon at [email protected] or +1 917-971-7852.

About Faex Health
Faex Health is a health technology company that has developed AI-powered solutions for preventive gastrointestinal health monitoring. Using computer vision, machine learning, and smartphone-based image analysis, the Faex platform helps users capture digestive health information, monitor patterns over time, and access personalized educational wellness insights. The company has developed solutions designed to support individuals, healthcare providers, health plans, employers, and population health organizations. Faex Health’s investigational clinical applications are intended to complement established medical screening and diagnostic pathways, not replace them. For more information, visit FaexHealth.com. Continue the conversation on LinkedIn, Facebook, TikTok, X, Reddit, and Instagram.

SOURCE Faex Health

Numa Triples ARR, Raises $45M Series C to Run the Entire Dealership

Led by Blue Cloud Ventures, the round brings total funding to $96 million, with more than 1,500 dealerships across the U.S. and Canada already running on Numa’s AI Operating System

SAN FRANCISCO, Nov. 16, 2026 — Numa, the AI Operating System for dealerships, today announced a $45 million Series C led by Blue Cloud Ventures, with participation from Threshold Ventures, Costanoa, Touring Capital, Gradient Ventures and Tokio Marine Future Fund. The round brings Numa’s total funding to $96 million. It caps a year in which Numa tripled in size, tripled its annual recurring revenue and became the AI system GM, FordDirect, BMW and Stellantis each put in front of their dealerships.

Numa has already won the hardest part of the dealership: the customer conversation. The system has handled more than 1 billion calls, texts and chats and booked more than 4 million appointments. Dealerships that run on Numa stay and grow with it. Net revenue retention has risen over the past year, and more dealerships are moving to longer agreements.

For decades, dealership software was built one task at a time. Each system kept its own record of what happened, and none of them acted on what the customer just said. The first wave of AI did not change that. It answered faster, then handed the work back to people to chase by hand.

Numa does not hand the work back. It knows not just who the customer is but what they need, and it acts on it: booking the visit, finding the right car, routing the call or flagging the customer about to leave.

“In two years, every general manager will have an AI COO,” said Tasso Roumeliotis, founder and CEO of Numa. “At more than 1,500 dealerships, they already do, and it is Numa. It knows every conversation in the store, sees what needs attention and runs the work that follows. That is not another dashboard or another point tool. It is an operating system. The DMS was built to record the dealership. It was never built to run it. Numa was, and this round puts more engineers to accelerate it.”

“What is unique about Numa is that the company understands the DNA and culture of a dealership and seamlessly AI-enables the workflow while empowering all constituents including the dealerships customers”, added Mir Arif, Managing Partner of Blue Cloud Ventures.  “Numa is not prescriptive but rather deeply understands the objectives of the BDC representative, the salesperson, the service technician, the parts specialist and the sales manager and significantly enhances their productivity.” 

“As an insurer, we view dealerships as a critical part of the ecosystem that supports customers throughout their vehicle ownership journey,” said Mitsutoshi Shizuru, Managing Executive Officer of Tokio Marine & Nichido Fire Insurance Co., Ltd, “Numa is using AI to make this important customer touchpoint faster, more efficient, and more seamless. We believe Numa’s technology has the potential to revolutionize the relationship between dealerships and their customers and help shape the next generation of mobility customer experiences in the U.S. and beyond.”

This year, Numa took its system across the whole store.

In the service lane, Numa already knows every conversation. In August, Numa acquired SocketTime to put the work behind those conversations into the same system, so what a customer tells the store and what the store does about it run in one place.

In sales, Numa for Sales, launched this month, as the first agent with Inventory Fluency. It knows every new and used vehicle on the lot down to the trim, features and miles, learns each buyer’s situation and gets them in the car that fits best, even when the one they called about has sold. Every qualified lead lands in the dealership’s CRM with the full conversation, so the salesperson who picks it up already knows the buyer.

On every line into the store, Operator, launched in September, is the first Precision Routing system for dealerships. It answers first, understands why each customer is calling and puts them in the right hands with that reason carried through. When the phone rings, everyone at the dealership knows the call is for them. Operator continues to climb above 95% with calls going to the right destination.

LiveCSI™ reads customer interactions as they happen and flags the ones putting satisfaction at risk while there is still time to fix them, instead of waiting for a survey to report what went wrong. In 90 days, it analyzed 50 million interactions.

Every dealership on Numa now has over 25+ natural voices to choose from, with regional accents, a new Spanish voice, sharper recognition of vehicle makes, models and VINs, and adjustable speaking speed. The voice on the line sounds like someone who works at the dealership. It comes at no added cost, with nothing for the store to set up.

Three of the largest automakers in North America have each chosen Numa. GM named Numa an iMR Approved Turnkey Vendor, and more than 240 GM dealerships run on Numa today. In those stores, reply times have dropped from 23 hours to 24 minutes, each store saves about $11,000 a month, and 86% of customers flagged as heat cases return for service within six months. FordDirect selected Numa as its strategic AI vendor, making Numa available to more than 3,000 Ford and Lincoln dealerships. Numa is also approved on Stellantis’ MarketCenter, opening access to more than 2,600 dealerships in the U.S. and 440 in Canada.

The operating system for the dealership is not on its way. It is already running.

To learn more, visit numa.com.

About Numa

Numa is the AI Operating System used by leading dealerships to modernize customer operations across voice, text, service, sales, fixed operations, and customer intelligence. Built for the complexity of dealership workflows, Numa combines AI agents, human-in-the-loop collaboration, operational intelligence, and LiveCSI™ to help dealerships respond faster, improve customer experience, increase productivity, identify store-level patterns, and run more intelligently.

Numa answers every call, books appointments, and protects CSI in real time, unifying every customer conversation across voice, text, and digital channels in one system.

Trusted by more than 1,500 dealerships across the U.S. and Canada, Numa is based in Silicon Valley and was founded by the team behind Location Labs. The company has raised $96 million from investors including Blue Cloud Ventures, Google, Threshold Ventures (founding investor of Tesla), Mitsui, Costanoa Ventures, Touring Capital, and Tokio Marine Future Fund. Inc. 5000 recognized Numa as the #443 fastest-growing company overall and the #1 fastest-growing dealership software company.

About Blue Cloud Ventures

Blue Cloud Ventures is a New York City-based venture growth firm that invests in leading AI software, AI infrastructure and cybersecurity companies. BCV has a track record of supporting visionary entrepreneurs from growth to exit, with a portfolio of over 55 category-defining software companies in the United States and Europe.

SOURCE Numa

Remedy Robotics Raises $62 Million Series B to Bring Life-Saving Cardiovascular Intervention to Patients Everywhere

Funding will support clinical trials, advancement toward FDA approval, and planned commercial deployment of the company’s AI-enabled endovascular robotic platform and software suite

SAN FRANCISCO, Nov. 16, 2026 — Remedy Robotics, Inc. (“Remedy”), a leading healthcare and physical AI company developing robotic systems for cardiovascular care and endovascular intervention, today announced it has raised $62 million in Series B funding to accelerate its mission of delivering flawless, immediate robotic care to all patients, regardless of location.

The funding will support several major milestones, including a planned pivotal clinical trial in partnership with the University of California and advancement toward FDA approval for neurovascular intervention. Remedy will also deploy prototype N1 Systems across its network of clinical partners, including through its strategic partnerships with SVIN Mission Thrombectomy and the Australian Stroke Alliance, while continuing to advance the system’s industry-leading AI capabilities and autonomous functions.

“Endovascular intervention is the gold standard treatment for stroke and many cardiovascular emergencies, yet access remains limited to a small number of hospitals. For these time-critical conditions, that’s devastating. Even when specialist intervention is available, treatment is often delayed, and complications are frustratingly common,” said Dr. David Bell, CEO and Co-founder of Remedy Robotics. “This funding will allow us to accelerate toward deployment of our N1 System so we can bring quality intervention to patients everywhere, regardless of geography.”

DCVC led the Series B, with participation from new investors including UC Investments (the University of California’s investment office), Skip Capital, and Hostplus (one of Australia’s largest pension funds). Existing investors Build Collective by Tony Fadell, Blackbird, Divergent Capital and KdT Ventures doubled down.

“Remedy Robotics represents a new generation of medical robotics and physical AI companies, focused not only on technical innovation, but on solving real-world challenges,” said James Hardiman, General Partner at DCVC. “We believe the company is uniquely positioned to redefine how life-saving intervention is delivered and are thrilled to support them as they advance toward broader clinical and commercial adoption.”

Remedy is finalizing development of the N1 System, an AI-enabled robotic platform and software suite that uses machine learning to analyze preoperative imaging, simulate cases in advance, provide real-time 3D-2D image registration and complete entire endovascular procedures robotically. Designed for on-site, remote, or autonomous operation, the system has the potential to dramatically expand access to and improve the quality of specialized neurovascular, coronary, and peripheral vascular care. Remedy now works with more than 100 hospitals worldwide and is among a small group of physical AI companies bringing robotics into real-world clinical use. In October 2025, Remedy announced that it had successfully completed the world’s first remote neurointerventional procedures using the N1 System.

“This funding will allow our world-leading hardware, software, and machine learning teams to progress the N1 system towards clinical trials and potential FDA approval, while also developing additional features including full autonomy,” said Jake Sganga, CTO and Co-founder of Remedy Robotics. “We are particularly excited to deepen our partnership with the University of California, having worked closely with their clinical experts since 2021, and as we prepare for our planned pivotal clinical trials to be held across the UC network.”

“Remedy is building the kind of company we look for at Blackbird: one with world-class technical talent, a massive global problem to solve, and the potential to create an entirely new category,” said Michael Tolo, Partner at Blackbird. “We believe Remedy is uniquely positioned to transform how endovascular care is delivered, and we are excited to support the company through its next phase of growth.”

Cardiovascular disease, including stroke and heart attack, is the leading cause of death globally—claiming nearly 20 million lives each year—about twice the toll of all cancers. Beyond the human cost, stroke alone carries an annual economic burden of approximately $891 billion worldwide through healthcare costs and lost productivity. Access to endovascular intervention, the most effective treatment for many cardiovascular conditions, remains severely limited because only highly specialized physicians at a small number of hospitals can perform it. Today, just 2.8 percent of eligible stroke patients worldwide have access to endovascular treatment, leaving millions each year with otherwise preventable disability. Because cardiovascular emergencies are so time-critical, patient outcomes vary sharply based on proximity to specialized care, even in countries with well-developed specialist networks, such as the United States. Remedy’s technology directly addresses this access gap, delivering expert care for stroke, severe heart attacks, hemorrhagic conditions, and other time-critical cardiovascular emergencies to patients wherever they are.

Remedy aims to elevate the standard of care across the cardiovascular continuum, from diagnosis to discharge and surveillance, with the goal of making flawless, immediate cardiovascular care available to patients everywhere, from San Francisco to rural areas of Arkansas where timely care is out of reach, or to Lagos, Nigeria, where intervention is almost entirely unavailable.

The N1 System is under development and is not currently available for sale or clinical use in any jurisdiction.

About Remedy Robotics
Remedy Robotics is a leading healthcare and physical AI company developing AI-enabled endovascular robotic systems and software for on-premise, remote, and autonomous intervention. Its proprietary N1 System combines robotics, AI, and advanced computer vision to raise the standard of care across the cardiovascular continuum—from diagnosis and intervention to discharge and surveillance—bringing expert-level treatment within reach of patients wherever they are. Remedy’s clinical and research work has been published in leading peer-reviewed journals, including Interventional Neuroradiology and the American Journal of Neuroradiology, and the company holds 48 patents covering its platform, including foundational patents in machine learning applied to surgical robotics. Headquartered in San Francisco, Remedy is backed by DCVC, Blackbird, UC Investments (the University of California’s investment office), and Tony Fadell’s Build Collective, among others, and partners with clinicians at leading medical institutions across the U.S. and worldwide. Remedy is also the exclusive robotic partner of SVIN Mission Thrombectomy, a global initiative dedicated to expanding access to stroke treatment worldwide. Learn more at www.remedyrobotics.com.

SOURCE Remedy Robotics, Inc.

Accountable Launches to Give Power to American Taxpayers

Co-founded by Acorns CEO Noah Kerner and Jeff Cruttenden, Accountable raises $20 million to help Americans file their taxes, follow their money, and ultimately decide how it is spent.

NEW YORK, Nov. 16, 2026 — Accountable, a new consumer tax and civic company, launched its waitlist today with the belief that taxpayers should be treated like investors in the country they fund. Investors expect transparency into how their money is put to work, accountability for how it is managed, and a voice in the decisions that shape where it goes. Taxpayers deserve the same.

Every year, Americans file more than 160 million federal income tax returns, while individuals— not corporations—account for roughly 85% of federal tax revenue. The average taxpayer spends about 12 hours preparing and completing a return, only to be left with a larger question once it’s filed: what did their money actually pay for?

Accountable’s first product, a tax filing platform designed around the needs of the taxpayer, will launch in January 2027 ahead of tax season. With a filer’s permission, Accountable retrieves available tax information and documents, prefills their return, and guides them through reviewing and submitting for one flat price of $76, with filing free for anyone experiencing financial hardship. Accountable customers will also receive a personalized taxpayer receipt showing an estimated breakdown of what their taxes fund across federal, state, and local government spending.

“Cumulatively, taxes are the largest check most of us will ever write, and it’s ridiculous that we don’t even get a receipt,” said Noah Kerner, co-founder of Accountable. “Taxpayers deserve a better experience: smart, fast and fair filing, transparency into what we’re paying for, and power over where our money goes. After all, it’s our money, we fund this country, and we should feel like shareholders in it.”

The filing platform is the first step in Accountable’s broader vision: help Americans file their taxes, follow their money and, over time, have a greater voice in how it is spent. Accountable is starting with filing because it is the most direct financial interaction most Americans have with government. Each year, Americans are asked to account for every dollar they earn. Accountability should go both ways.

For Kerner, Accountable is a continuation of a career spent giving everyday people more access and agency in complex financial systems. At Acorns, Kerner has helped over 15 million everyday Americans save & invest over $30 billion. At Say, he gave individual investors a voice in the companies they own. At Accountable, he wants to give taxpayers the same voice in the country they fund. The full team behind Accountable comes with a wealth of experience across tax, civic, investing, health, and consumer technology sectors.

“We backed Accountable because we believe the taxpayer is one of the biggest consumer categories still waiting to be reinvented,” said Lauren Kolodny, Founding Partner at Acrew Capital. “Noah has spent his career earning the trust of everyday Americans. With Accountable, he’s bringing that same consumer-first mindset to one of the most important financial relationships in their lives.”

“Americans have more tools than ever to understand where their money goes, except when it goes to the government,” said Brent Murri, Partner at M13. “At M13, we look for founders who transform complex, entrenched systems into experiences that give people greater control. Accountable has the potential to fundamentally change the relationship between Americans and the government they fund.”

Accountable has raised $20 million in total funding, including a seed round co-led by Acrew Capital and M13, with participation from Greycroft, Torch Capital, Treasury, 645 Ventures, Eniac Ventures, Lerer Hippeau, Tusk Ventures, and angel investors like Josh Wolfe, founder of Lux Capital, and Zach Perret, co-founder of Plaid. The capital will support the buildout of Accountable’s filing platform and team ahead of its January launch. Kerner will continue to serve as CEO of Acorns.

Americans can join the waitlist beginning today at AccountableUSA.com.

About Accountable
Accountable is a consumer tax and civic company on a mission to bring Americans closer to America. Its first product, a tax platform designed to give Power to the Taxpayer, launches for the 2027 tax season. Join the waitlist at AccountableUSA.com.

SOURCE Accountable